- Home
- RVPH vs MBBC Comparison
RVPH vs MBBC Comparison
Compare RVPH & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- MBBC
- Stock Information
- Founded
- RVPH 2006
- MBBC 1902
- Country
- RVPH United States
- MBBC United States
- Employees
- RVPH N/A
- MBBC N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- MBBC Banks
- Sector
- RVPH Health Care
- MBBC Finance
- Exchange
- RVPH Nasdaq
- MBBC Nasdaq
- Market Cap
- RVPH 32.8M
- MBBC 29.3M
- IPO Year
- RVPH N/A
- MBBC N/A
- Fundamental
- Price
- RVPH $0.38
- MBBC $9.98
- Analyst Decision
- RVPH Strong Buy
- MBBC
- Analyst Count
- RVPH 5
- MBBC 0
- Target Price
- RVPH $9.00
- MBBC N/A
- AVG Volume (30 Days)
- RVPH 2.8M
- MBBC 10.3K
- Earning Date
- RVPH 08-13-2025
- MBBC 08-22-2025
- Dividend Yield
- RVPH N/A
- MBBC N/A
- EPS Growth
- RVPH N/A
- MBBC 103.56
- EPS
- RVPH N/A
- MBBC 0.22
- Revenue
- RVPH N/A
- MBBC $6,591,743.00
- Revenue This Year
- RVPH N/A
- MBBC N/A
- Revenue Next Year
- RVPH N/A
- MBBC N/A
- P/E Ratio
- RVPH N/A
- MBBC $45.31
- Revenue Growth
- RVPH N/A
- MBBC N/A
- 52 Week Low
- RVPH $0.30
- MBBC $6.38
- 52 Week High
- RVPH $4.28
- MBBC $12.00
- Technical
- Relative Strength Index (RSI)
- RVPH 31.86
- MBBC N/A
- Support Level
- RVPH $0.35
- MBBC N/A
- Resistance Level
- RVPH $0.83
- MBBC N/A
- Average True Range (ATR)
- RVPH 0.06
- MBBC 0.00
- MACD
- RVPH -0.02
- MBBC 0.00
- Stochastic Oscillator
- RVPH 14.45
- MBBC 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.